BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast
,
Hematopoietic cell
,
Doxorubicin
,
rs2300478
,
PTEN
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
factor hs
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Gliosis-dependent expression of complement factor H truncated variants attenuates retinal neurodegen…
Mechanisms by which Factor H protects Trypanosoma cruzi from the alternative pathway of complement.
Protective role of complement factor H against the development of preeclampsia.
The human factor H protein family - an update.
Complement factor H: a guardian within?
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer
Fractional CO2 Laser Fenestration and Steroid Delivery in HS Lesions
Phaseâ… Study of the HS-10241 in Patients With Advanced Solid Tumors
A Phase 1 Study of HS-10342 In Patients With Advanced Solid Tumor
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ